Evidence map›Paper›PMID 42847645›Full record

ArticleJournal of Parkinson's disease2026

Measuring what matters: Evaluating quality of life instruments through the eyes of people with Parkinson's disease.

Samantha Dorrance, Richa Patel, Glenn T Stebbins, Jamie L Adams, Allison Allen, Tara Hastings, Soania Mathur, Onanong Phokaewvarangkul, Gary Rafaloff, Rajasumi Rajalingam and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of Parkinson's disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Samantha DorranceEdmond J. Safra Program in Parkinson's Disease and Morton and Gloria Shulman Movement Disorders Clinic, University Health Network, Toronto, ON, Canada.ORCID 0009-0002-2488-0244
Richa PatelEdmond J. Safra Program in Parkinson's Disease and Morton and Gloria Shulman Movement Disorders Clinic, University Health Network, Toronto, ON, Canada.ORCID 0009-0004-6180-7892
Glenn T StebbinsDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA.ORCID 0000-0001-7905-9336
Jamie L AdamsDepartment of Neurology, University of Rochester, Rochester, NY, USA.ORCID 0000-0002-1170-6688
Allison AllenDuke University Medical Center, Durham, NC, USA.ORCID 0000-0002-2039-6773
Tara HastingsSanofi, Morristown, NJ, USA.
Soania MathurParkinson's Research Advocate, Toronto, ON, Canada.ORCID 0000-0002-6224-7573
Onanong PhokaewvarangkulChulalongkorn Centre of Excellence for Parkinson's Disease & Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.ORCID 0000-0003-0060-9935
Gary RafaloffParkinson's Research Advocate, Westlake, FL, USA.ORCID 0000-0002-2625-2025
Rajasumi RajalingamEdmond J. Safra Program in Parkinson's Disease and Morton and Gloria Shulman Movement Disorders Clinic, University Health Network, Toronto, ON, Canada.ORCID 0000-0002-2564-7375
Anette SchragDepartment of Clinical and Movement Neurosciences, UCL Institute of Neurology, University College London, London, UK.ORCID 0000-0002-9872-6680
Christine SunEdmond J. Safra Program in Parkinson's Disease and Morton and Gloria Shulman Movement Disorders Clinic, University Health Network, Toronto, ON, Canada.
Jennifer MammenUniversity of Massachusetts, Dartmouth, MA, USA.ORCID 0000-0001-7858-9183
Connie MarrasEdmond J. Safra Program in Parkinson's Disease and Morton and Gloria Shulman Movement Disorders Clinic, University Health Network, Toronto, ON, Canada.ORCID 0000-0002-9236-9328

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundMany instruments are used to assess quality of life in people living with Parkinson's disease. However, there is limited understanding of what people living with Parkinson's consider relevant and important when measuring quality of life.AimTo explore what people living with Parkinson's consider relevant and important in the assessment of quality of life.MethodsSemi-structured interviews were conducted with 31 people living with Parkinson's disease. Participants completed eight instruments, which were used to guide discussion and reflection on what helps and what hinders measuring quality of life in a way that is meaningful to them.ResultsParticipants highlighted a number of features they consider important in the assessment of quality of life. These include being able to select from a wide range of response options, addressing the personal, emotional, and practical impacts of issues, using clear, specific language, and including a balance of questions that address both positive and negative aspects of the Parkinson's experience.ConclusionsThere is a need for instruments that reflect the complex and varied ways Parkinson's disease affects individuals. While existing questionnaires incorporate some features that support meaningful assessment, participants also identified features that may hinder the extent to which quality of life is adequately captured and that warrant further refinement. Incorporating feedback from people with lived experience may help inform future evaluation and refinement of quality of life measures in research and care.

Indexed as

measurementParkinson's diseasepatient-reportqualitativequality of life

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.